Katia Finck

Angestellt, Senior Director, Head of Market Access Europe & MEA, Onyx Pharmaceuticals

Zug, Schweiz

Fähigkeiten und Kenntnisse

Market Access
Pricing & Reimbursement
Health Economics
Public Affairs
Regulation
Public Policies
Pricing governance
Health Technologies Assessment
Orphan drugs
Oncology
National reimbursement
vaccines
Pricing surveys
Patient advocacy
European Commission
Global pricing
Commercial Operations

Werdegang

Berufserfahrung von Katia Finck

  • Bis heute

    Senior Director, Head of Market Access Europe & MEA

    Onyx Pharmaceuticals

  • 5 Jahre und 10 Monate, Juni 2007 - März 2013

    Director Market Access and Public Affairs EMEA

    Shire Pharmaceuticals

    Developed and implemented EMEA regional Pricing & Reimbursement strategies for new orphan drugs and sustain their values throughout their lifecycles; Provided and implemented Public Affairs strategies to raise the profile of Shire in the Orphan Diesease community and influence policy and access for the brands in the EU region

  • 1 Jahr und 10 Monate, Sep. 2005 - Juni 2007

    Global Senior Pricing & Reimbursement

    GlaxoSmithkine

    Developed global Pricing & Reimbursement strategies for new vaccines launches according to pricing process and in line with commercial strategies

Sprachen

  • Englisch

    -

21 Mio. XING Mitglieder, von A bis Z